Cardioprotective effects of lazaroid U-74389G on ischemia-reperfusion injury in canine hearts

Journal of Heart and Lung Transplantation

Volumn 18, Issue 4, 1999, Pages 285-291

  Takahashi, Toru ^a   Takeyoshi, Izumi ^a   Hasegawa, Yutaka ^a   Koyano, Tetsuya ^a   Yamagishi, Toshiharu ^a   Oshima, Kiyohiro ^a   Matsumoto, Koshi ^b   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; LAZAROID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOG; DRUG EFFECT; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0032914792     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00068-0     Document Type: Article

References (22)

1. Braughler J.M., Pregenzer J.F., Chase R.L., Duncan L.A., Jacobsen E.J., McCall J.M. Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem. 262:1987;10438-10440.
2. Shenker R., Abraham E. Effects of treatment with the 21-aminosteroid, U74389F, on pulmonary cytokine expression following hemorrhage and resuscitation. Crit Care Med. 23:1995;132-139.
3. Lower R.R., Shumway N.E. Studies on orthotopic homotransplantation of the canine heart. Surg Forum. 11:1960;18-19.
4. Morishita Y. Orthotopic allotransplantation of the preserved canine heart. Acta Med Univ Kagoshima. 16:1974;108-125.
5. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. New Eng J Med. 312:1985;159-163.
6. Shenkar R., Abraham E. Effects of treatment with the 21-aminosteroid, U74389F, on pulmonary cytokine expression following hemorrhage and resuscitation. Crit Care Med. 23:1995;132-139.
7. Balla G., Vercellotti G.M., Eaton J.W., Jacob H.S. Iron loading of endothelial cells augments oxidant damage. J Lab Clin Med. 116:1990;546-554.
8. Gadaleta D., Verma M., Davis J.M. Inhibition of neutrophil leukotriene generation by the 21-aminosteroid, U74389F. J Surg Res. 57:1994;233-237.
9. Hall E.D., Pazara K.E., Braughler J.M. 21-aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils. Stroke. 19:1988;997-1002.
10. Perkins W.J., Milde L.N., Milde J.H., Michenfelder J.D. Pretreatment with U74006F improves neurologic outcome following complete cerebral ischemia in dogs. Stroke. 22:1991;902-909.
11. Todo S., Hamada N., Zhu Y., et al. Lazaroid U-74389G for 48-hour canine liver preservation. Transplantation. 61:1996;189-194.
12. Ishizaki N., Zhu Y., Zhang S., et al. Comparison of various lazaroid compounds for protection against ischemic liver injury. Transplantation. 63:1997;202-208.
13. Garvin P.J., Niehoff M.L., Robinson S.M., et al. Renoprotective effects of the 21-aminosteroid U74389G in ischemia-reperfusion injury and cold storage preservation. Transplantation. 63:1997;194-201.
14. Holzgrefe H.H., Buchanan L.V., Gibson J.K. Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium. J Cardiovasc Pharmacol. 15:1990;239-248.
15. Carrea F.P., Lesnefsky E.J., Kaiser D.G., Horwitz L.D. The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion. J Cardiovasc Pharmacol. 20:1992;230-235.
16. Hendry P.J., Anstadt M.P., Plunkett M.D., Amato M.T., Menius J.A. Jr, Lowe J.E. Improved donor myocardial recovery with a new lazaroid lipid antiperoxidant in the isolated canine heart. J Heart Lung Transplant. 11:1992;636-645.
17. Nishida T., Morita S., Miyamoto K., et al. The effect of lazaroid (U74500A), a novel inhibitor of lipid peroxidation, on 24-hour heart preservation. Transplantation. 61:1996;194-199.
18. Duguay P., Chen H., Daloze P., Dumont L. Cardioprotective effects of the lazaroid U74389G following cold preservation and transplantation of rat hearts. Transplantation. 61:1996;1023-1028.
19. Tanoue Y., Morita S., Ochiai Y., et al. Inhibition of lipid peroxidation with the lazaroid U74500A attenuates isch-emia-reperfusion injury in canine orthotopic heart trans-plantation model. J Thorac Cardiovasc Surg. 112:1996;1017-1026.
20. Fleishaker J.C., Peters G.R., Cathcart K.S. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: I. single-dose administration. J Clin Pharmacol. 33:1993;175-181.
21. Fukuhara T. Histochemical, ultrastructural and cytochemical study of reperfusion effect on ischemic myocardial injury. Jpn Circ J. 49:1985;432-445.
22. Schaper J., Schaper W. Reperfusion of ischemic myocardium ultrastructural and histochemical aspects . J Am Coll Cardiol. 1:1983;1037-1046.